Small-caps poised to outperform thanks to biotechs, regional banks and reshoring

Mike Rode, senior investment director at American Century Investments, sits down with InvestmentNews anchor Gregg Greenberg to explain why small-caps are set to outperform due to the rise of reshoring, new IPOs and biotechs.
More: IN THE NASDAQ
Knighthead Insurance Group CEO highlights successful product rollout

Knighthead Insurance Group CEO highlights successful product rollout

Here’s what’s behind the boom in derivative income ETFs

Here’s what’s behind the boom in derivative income ETFs

Schwab Center strategist offers outlook for inflation, jobs and stocks

Schwab Center strategist offers outlook for inflation, jobs and stocks